nodes	percent_of_prediction	percent_of_DWPC	metapath
Propantheline—Mydriasis—Varenicline—nicotine dependence	0.0993	0.129	CcSEcCtD
Propantheline—Salivary hypersecretion—Varenicline—nicotine dependence	0.0769	0.0999	CcSEcCtD
Propantheline—Thirst—Varenicline—nicotine dependence	0.0604	0.0784	CcSEcCtD
Propantheline—Abdominal distension—Varenicline—nicotine dependence	0.05	0.065	CcSEcCtD
Propantheline—Dysphagia—Varenicline—nicotine dependence	0.0497	0.0645	CcSEcCtD
Propantheline—Erectile dysfunction—Varenicline—nicotine dependence	0.0457	0.0594	CcSEcCtD
Propantheline—Vision blurred—Varenicline—nicotine dependence	0.0326	0.0424	CcSEcCtD
Propantheline—Palpitations—Varenicline—nicotine dependence	0.0306	0.0397	CcSEcCtD
Propantheline—Dry mouth—Varenicline—nicotine dependence	0.0288	0.0374	CcSEcCtD
Propantheline—Tachycardia—Varenicline—nicotine dependence	0.0276	0.0358	CcSEcCtD
Propantheline—Insomnia—Varenicline—nicotine dependence	0.0255	0.0332	CcSEcCtD
Propantheline—Somnolence—Varenicline—nicotine dependence	0.0251	0.0326	CcSEcCtD
Propantheline—Constipation—Varenicline—nicotine dependence	0.0242	0.0314	CcSEcCtD
Propantheline—Feeling abnormal—Varenicline—nicotine dependence	0.0233	0.0302	CcSEcCtD
Propantheline—Urticaria—Varenicline—nicotine dependence	0.0224	0.0291	CcSEcCtD
Propantheline—Hypersensitivity—Varenicline—nicotine dependence	0.0208	0.027	CcSEcCtD
Propantheline—Asthenia—Varenicline—nicotine dependence	0.0203	0.0263	CcSEcCtD
Propantheline—Dizziness—Varenicline—nicotine dependence	0.0187	0.0243	CcSEcCtD
Propantheline—Vomiting—Varenicline—nicotine dependence	0.018	0.0233	CcSEcCtD
Propantheline—Rash—Varenicline—nicotine dependence	0.0178	0.0231	CcSEcCtD
Propantheline—Dermatitis—Varenicline—nicotine dependence	0.0178	0.0231	CcSEcCtD
Propantheline—Headache—Varenicline—nicotine dependence	0.0177	0.023	CcSEcCtD
Propantheline—Nausea—Varenicline—nicotine dependence	0.0168	0.0218	CcSEcCtD
Propantheline—CHRM1—Monoamine GPCRs—DRD2—nicotine dependence	0.00989	0.0429	CbGpPWpGaD
Propantheline—CHRM3—Monoamine GPCRs—DRD2—nicotine dependence	0.00985	0.0428	CbGpPWpGaD
Propantheline—CHRM2—Monoamine GPCRs—DRD2—nicotine dependence	0.00976	0.0424	CbGpPWpGaD
Propantheline—CHRM1—Amine ligand-binding receptors—DRD2—nicotine dependence	0.00831	0.0361	CbGpPWpGaD
Propantheline—CHRM3—Amine ligand-binding receptors—DRD2—nicotine dependence	0.00828	0.036	CbGpPWpGaD
Propantheline—CHRM2—Amine ligand-binding receptors—DRD2—nicotine dependence	0.0082	0.0356	CbGpPWpGaD
Propantheline—CHRM1—Regulation of Actin Cytoskeleton—FGD1—nicotine dependence	0.00762	0.0331	CbGpPWpGaD
Propantheline—CHRM3—Regulation of Actin Cytoskeleton—FGD1—nicotine dependence	0.0076	0.033	CbGpPWpGaD
Propantheline—CHRM2—Regulation of Actin Cytoskeleton—FGD1—nicotine dependence	0.00752	0.0327	CbGpPWpGaD
Propantheline—CHRM2—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.00666	0.0289	CbGpPWpGaD
Propantheline—CHRM2—SIDS Susceptibility Pathways—CHRNB4—nicotine dependence	0.00571	0.0248	CbGpPWpGaD
Propantheline—CHRM1—Regulation of Actin Cytoskeleton—WASF2—nicotine dependence	0.00474	0.0206	CbGpPWpGaD
Propantheline—CHRM3—Regulation of Actin Cytoskeleton—WASF2—nicotine dependence	0.00473	0.0205	CbGpPWpGaD
Propantheline—CHRM2—Regulation of Actin Cytoskeleton—WASF2—nicotine dependence	0.00468	0.0203	CbGpPWpGaD
Propantheline—CHRM1—Regulation of Actin Cytoskeleton—WASF1—nicotine dependence	0.00455	0.0197	CbGpPWpGaD
Propantheline—CHRM3—Regulation of Actin Cytoskeleton—WASF1—nicotine dependence	0.00453	0.0197	CbGpPWpGaD
Propantheline—CHRM2—Regulation of Actin Cytoskeleton—WASF1—nicotine dependence	0.00449	0.0195	CbGpPWpGaD
Propantheline—CHRM1—GPCR ligand binding—TAS2R16—nicotine dependence	0.00408	0.0177	CbGpPWpGaD
Propantheline—CHRM3—GPCR ligand binding—TAS2R16—nicotine dependence	0.00407	0.0177	CbGpPWpGaD
Propantheline—CHRM2—GPCR ligand binding—TAS2R16—nicotine dependence	0.00403	0.0175	CbGpPWpGaD
Propantheline—CHRM2—SIDS Susceptibility Pathways—CHRNB2—nicotine dependence	0.00381	0.0165	CbGpPWpGaD
Propantheline—CHRM2—SIDS Susceptibility Pathways—CHRNA4—nicotine dependence	0.00346	0.015	CbGpPWpGaD
Propantheline—CHRM1—Circadian rythm related genes—CHRNB2—nicotine dependence	0.00315	0.0137	CbGpPWpGaD
Propantheline—CHRM2—G alpha (i) signalling events—OPRM1—nicotine dependence	0.00281	0.0122	CbGpPWpGaD
Propantheline—CHRM1—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00264	0.0115	CbGpPWpGaD
Propantheline—CHRM3—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00263	0.0114	CbGpPWpGaD
Propantheline—CHRM2—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.0026	0.0113	CbGpPWpGaD
Propantheline—CHRM1—Circadian rythm related genes—DRD2—nicotine dependence	0.00233	0.0101	CbGpPWpGaD
Propantheline—CHRM1—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00231	0.01	CbGpPWpGaD
Propantheline—CHRM3—GPCR downstream signaling—TAS2R16—nicotine dependence	0.0023	0.00999	CbGpPWpGaD
Propantheline—CHRM2—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00228	0.0099	CbGpPWpGaD
Propantheline—CHRM1—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00226	0.00982	CbGpPWpGaD
Propantheline—CHRM3—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00225	0.00979	CbGpPWpGaD
Propantheline—CHRM2—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00223	0.00969	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—TAS2R16—nicotine dependence	0.0021	0.0091	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—TAS2R16—nicotine dependence	0.00209	0.00907	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—TAS2R16—nicotine dependence	0.00207	0.00899	CbGpPWpGaD
Propantheline—CHRM2—G alpha (i) signalling events—DRD2—nicotine dependence	0.00203	0.00881	CbGpPWpGaD
Propantheline—CHRM1—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00191	0.00829	CbGpPWpGaD
Propantheline—CHRM3—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.0019	0.00826	CbGpPWpGaD
Propantheline—CHRM2—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00188	0.00818	CbGpPWpGaD
Propantheline—CHRM1—GPCR downstream signaling—FGD1—nicotine dependence	0.00181	0.00787	CbGpPWpGaD
Propantheline—CHRM3—GPCR downstream signaling—FGD1—nicotine dependence	0.00181	0.00784	CbGpPWpGaD
Propantheline—CHRM2—GPCR downstream signaling—FGD1—nicotine dependence	0.00179	0.00776	CbGpPWpGaD
Propantheline—CHRM1—GPCR ligand binding—OPRM1—nicotine dependence	0.00172	0.00748	CbGpPWpGaD
Propantheline—CHRM3—GPCR ligand binding—OPRM1—nicotine dependence	0.00172	0.00745	CbGpPWpGaD
Propantheline—CHRM2—GPCR ligand binding—OPRM1—nicotine dependence	0.0017	0.00738	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—FGD1—nicotine dependence	0.00164	0.00714	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—FGD1—nicotine dependence	0.00164	0.00712	CbGpPWpGaD
Propantheline—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00163	0.0071	CbGpPWpGaD
Propantheline—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00163	0.00708	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—FGD1—nicotine dependence	0.00162	0.00705	CbGpPWpGaD
Propantheline—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00161	0.00701	CbGpPWpGaD
Propantheline—CHRM1—GPCR ligand binding—DRD2—nicotine dependence	0.00124	0.00541	CbGpPWpGaD
Propantheline—CHRM3—GPCR ligand binding—DRD2—nicotine dependence	0.00124	0.00539	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—TAS2R16—nicotine dependence	0.00124	0.00538	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—TAS2R16—nicotine dependence	0.00123	0.00536	CbGpPWpGaD
Propantheline—CHRM2—GPCR ligand binding—DRD2—nicotine dependence	0.00123	0.00534	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—TAS2R16—nicotine dependence	0.00122	0.00531	CbGpPWpGaD
Propantheline—CHRM1—GPCR downstream signaling—OPRM1—nicotine dependence	0.000973	0.00423	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—FGD1—nicotine dependence	0.000972	0.00422	CbGpPWpGaD
Propantheline—CHRM3—GPCR downstream signaling—OPRM1—nicotine dependence	0.00097	0.00421	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—FGD1—nicotine dependence	0.000968	0.00421	CbGpPWpGaD
Propantheline—CHRM2—GPCR downstream signaling—OPRM1—nicotine dependence	0.00096	0.00417	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—FGD1—nicotine dependence	0.000959	0.00417	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—CYP2A7—nicotine dependence	0.000951	0.00413	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—OPRM1—nicotine dependence	0.000884	0.00384	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—OPRM1—nicotine dependence	0.000881	0.00383	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—OPRM1—nicotine dependence	0.000872	0.00379	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—AKR1B10—nicotine dependence	0.000858	0.00373	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—AKR1B10—nicotine dependence	0.000855	0.00372	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—AKR1B10—nicotine dependence	0.000847	0.00368	CbGpPWpGaD
Propantheline—CHRM1—GPCR downstream signaling—DRD2—nicotine dependence	0.000703	0.00306	CbGpPWpGaD
Propantheline—CHRM3—GPCR downstream signaling—DRD2—nicotine dependence	0.000701	0.00305	CbGpPWpGaD
Propantheline—CHRM2—GPCR downstream signaling—DRD2—nicotine dependence	0.000694	0.00302	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—DRD2—nicotine dependence	0.000639	0.00277	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—DRD2—nicotine dependence	0.000637	0.00277	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—DRD2—nicotine dependence	0.000631	0.00274	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—WASF2—nicotine dependence	0.000605	0.00263	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—WASF2—nicotine dependence	0.000603	0.00262	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—WASF2—nicotine dependence	0.000597	0.00259	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—WASF1—nicotine dependence	0.00058	0.00252	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—WASF1—nicotine dependence	0.000578	0.00251	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—WASF1—nicotine dependence	0.000572	0.00249	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—OPRM1—nicotine dependence	0.000522	0.00227	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—OPRM1—nicotine dependence	0.00052	0.00226	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—OPRM1—nicotine dependence	0.000515	0.00224	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—DRD2—nicotine dependence	0.000377	0.00164	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—DRD2—nicotine dependence	0.000376	0.00163	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—DRD2—nicotine dependence	0.000373	0.00162	CbGpPWpGaD
